Pharmacotherapy for performance anxiety disorders: Occasionally useful but typically contraindicated

Journal of Clinical Psychology

Volumn 60, Issue 8, 2004, Pages 867-879

  Birk, Lee ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

D cycloserine (DCS); Exposure based therapy; Extinction of fear responses; Performance anxiety

Indexed keywords

BENZODIAZEPINE; CYCLOSERINE; DIAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; VENLAFAXINE;

ADULT; AIRPLANE CREW; AMYGDALOID NUCLEUS; ANXIETY DISORDER; CAREER; CASE REPORT; CLINICAL ARTICLE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; FEAR; GROUP THERAPY; HUMAN; JOB PERFORMANCE; MALE; PANIC; PERFORMANCE; PERFORMANCE ANXIETY; PHOBIA; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; SEX THERAPY; SEXUAL BEHAVIOR; SOCIAL PHOBIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; VIRTUAL REALITY;

ANTIMETABOLITES; ANXIETY DISORDERS; CYCLOSERINE; EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; PANIC DISORDER; SPEECH; TASK PERFORMANCE AND ANALYSIS;

EID: 3242814566     PISSN: 00219762     EISSN: None     Source Type: Journal    
DOI: 10.1002/jclp.20044     Document Type: Review

References (19)

1. Barlow, D.H. (2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). New York: Guilford.
2. Birk, L. (1999). Cognitive behavior therapy and systemic behavioral psychotherapy. In A. Nicholi (Ed.), Harvard guide to psychiatry (3rd ed.). Cambridge, MA: Harvard University Press.
3. Brown, T.A., Antony, M.M., & Barlow, D.H. (1995). Diagnostic comorbidity in panic disorder: Effect on treatment outcome and course of comorbid diagnoses following treatment. Journal of Consulting and Clinical Psychology, 63, 405-418.
4. Davis, M. (2003a). Role of the amygdala in fear extinction measured with potential startle. Annals of the New York Academy of Sciences, 985, 218-232.
5. Davis, M. (2003b, November). The role of NMDA receptors in extinction. Paper presented at the annual meeting of the Society for Neuroscience, New Orleans.
6. Foa, E., & Kozak, M. (1986). Emotional processing of fear: Exposure to corrective information Psychological Bulletin, 99, 20-35.
7. Friedman, S., Jones, J.C., Chernen, L., & Barlow, D.H. (1992). Suicidal ideation and suicide attempts among patients with panic disorder. American Journal of Psychiatry, 149, 680-685.
8. Johnson, J., Weissman, M.M., & Klerman, G.L. (1990). Panic disorder, comorbidity, and suicide attempts. Archives of General Psychiatry, 47, 805-808.
9. Marks, I.M., Swinsan, R.P., Basaglu, M., Kuch, K., Nashirvani, H., O'Sullivan, G., Lelliott, P.T., Kirby, M., McNamee, G., Sengun, S., & Wickwire, K. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraophobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776-787.
10. Otto, M.W., Pollack, M.H., & Sabatino, S.A. (1996). Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment. Behavior Therapy, 27, 473-482.
11. Otto, M.W., Pollack, M.H., Sachs, G.S., Teiter, S.R., Meltzer-Brody, S., & Rosenbaum, J.F. (1993). Discontinuation of benzodiazepine treatment: Efficacy of cognitive behavior therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485-1490.
12. Ressler, K.J., Rothbaum, B.O., Tannenbaum, L., Anderson, P., Zimand, E., Hodges, L., & Davis, M. (in press). Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobics to facilitate extinction of fear. Archives of General Psychiatry.
13. Spiegel, D.A., Bruce, T.J., Gregg, S.F., & Nuzzarello, A. (1994). Does cognitive behavior therapy assist slow taper alprazolam discontinuation in panic disorder? American Journal of Psychiatry, 151, 876-881.
14. Spiegel, D.A., Wiegel, M., Baker, S.L., & Greene, K.A.I. (2000). Pharmacotherapy of anxiety disorders. In D.I. Mostofsky & D.H. Barlow (Eds.), The management of stress and anxiety in medical disorders. Boston: Allyn & Bacon.
15. Stahl, S.M. (2000). Essential psychopharmacology: Neuroscientific basis and practical application. Cambridge: Cambridge University Press.
16. Stein, M.B. (2003). Attending to anxiety disorders in primary care. Journal of Clinical Psychiatry, 64, 35-39.
17. Turner, S.M., Beidel, D.C., & Jacob, R.G. (1994). Social phobia: A comparison of behavior therapy and atenolol. Journal of Consulting and Clinical Psychology, 62, 350-358.
18. Wilhelm, F.H., & Roth, W.T. (1997). Acute and delayed effects of alprazolam on flight phobics during exposure. Behavior Research & Therapy, 35, 831-841.
19. Wilhelm, F.H., & Roth, W.T. (1996, November). Acute and delayed effects of alprazolam on flight phobics during exposure. Paper presented at the 30th Annual Convention of the Association for the Advancement of Behavior Therapy, New York.